1. Cambridge, Mass.-based Ariad Pharmaceuticals recently earned marketing approval and a label expansion for its Leukemia drug Iclusig.
2. Clobestasol propionate lotion, developed by Buena, N.J.-based Teligent, is intended to treat skin conditions like eczema and psoriasis.
3. Baltimore-based Lupin Pharmaceuticals developed armodafinil tablets, which are intended to improve wakefulness in adults with excessive sleepiness.
4. The ConvertX Nephroureteral Stent System, developed by Mountain View, Calif.-based BrightWater Medical, is intended to treat patients with ureteral obstructions.
5. Philadelphia-based Lannett created metaxalone tablets — a muscle relaxant for patients with acute, painful musculoskeletal conditions.
More articles on supply chain:
Spearheading a first-of-its-kind logistics center: 5 questions with Dennis Mullins, VP of supply chain for IU Health
Trump picks Elaine Chao for transportation secretary: 7 things to know
How Amazon trains new warehouse workers in just 2 days
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
